Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Cognitive Decline After Chemotherapy, With Fluoxetine Treatment

NCT01615055 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01615055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01615055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Cognitive Decline After Chemotherapy, With Fluoxetine Treatment
Lead sponsor
University of California, Los Angeles
Phase
Phase 1
Overall status
Withdrawn
Start date
June 30, 2018
Completion date
October 31, 2020
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction